Jiani Zheng
Fuzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Oncogenic EGFR-SHC1 Fusion Confers Insensitivity to EGFR-TKIs via Dual Activation of N-EGFR Kinase Domain and C-SHC1 Phosphorylation Sites in Lung Cancer.
Journal: Cancer discovery
Published: November 01, 2025
FAK activation drives non-genetic adaptive survival of ALK-rearranged lung cancer under tyrosine kinase inhibitor treatment.
Journal: Journal of genetics and genomics = Yi chuan xue bao
Published: October 26, 2025
Activating NEDD4L suppresses EGFR-driven lung adenocarcinoma growth via facilitating EGFR proteasomal degradation.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 23, 2025
CCN1 is a therapeutic target upregulated in EML4-ALK mutant lung adenocarcinoma reversibly resistant to alectinib.
Journal: Cell death & disease
Published: September 08, 2024
Aldolase B impairs DNA mismatch repair and induces apoptosis in colon adenocarcinoma.
Journal: Pathology, research and practice
Published: January 22, 2019
Enhancement of surface graft density of MPEG on alginate/chitosan hydrogel microcapsules for protein repellency.
Journal: Langmuir : the ACS journal of surfaces and colloids
Published: August 28, 2012
Chitosan/VEGF-sIRNA nanoparticle for gene silencing.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 27, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026